Abstract
To evaluate the validity of self-reported lipid medication use in an epidemiological study. We studied medication self-reports compared with inventoried lipid medication containers at the fifth visit of the Atherosclerosis Risk in Communities (ARIC) Study in 2011-2013 (n = 6370). To assess the validity of self-reports, we computed sensitivity, specificity, positive and negative predictive values. We used multiple logistic regression to determine whether validity varied by participant characteristics. Comparisons were made with visit 4 (n = 11,531), to determine if there was a change in validity as the pattern and types of lipid medication used changed over time. The prevalence of lipid medication use, according to medication containers was higher at visit 5 (56%) than visit 4 (14.3%). Statins were increasingly used. The percentage of participants reporting use/non-use accurately was 91.8% at visit 5, lower than visit 4 (97.3%). The unadjusted kappa coefficient of agreement was 0.83 (95% CI - 0.82 to 0.85) at visit 5 and 0.89 (95% CI - 0.88 to 0.90) at visit 4. Agreement was higher, compared with their counterparts, for women, younger and more educated participants, and those using fewer total medications. In this population sam...Continue Reading
References
Jan 1, 1975·Journal of Chronic Diseases·B S HulkaR L Efird
Jun 1, 1992·Journal of Clinical Epidemiology·B M PsatyM Lyles
Jan 1, 1989·Journal of General Internal Medicine·J E JacksonH Ward
Oct 1, 1988·The Gerontologist·J A LandryW Simonson
Nov 1, 1974·British Journal of Preventive & Social Medicine·R GlassM Vessey
Jan 1, 1980·Journal of Chronic Diseases·D S Brody
Jul 15, 1998·British Journal of Clinical Pharmacology·S I SjahidB H Stricker
Apr 14, 1999·Journal of Clinical Epidemiology·N L SmithE S Cornell
Jan 27, 2004·American Journal of Epidemiology·Denise M BoudreauSusan R Heckbert
Oct 13, 2005·JAMA : the Journal of the American Medical Association·Margaret D CarrollClifford L Johnson
Feb 25, 2006·Pharmacoepidemiology and Drug Safety·Jeffrey R CurtisKenneth G Saag
Mar 3, 2007·Arthritis and Rheumatism·Daniel H SolomonNancy Shadick
Jul 20, 2010·Pharmacoepidemiology and Drug Safety·Ellen S KosterAnke-Hilse Maitland-van der Zee
Dec 4, 2012·BMC Health Services Research·Louisa G GordonAnna L Hawkes